Kerala Ayurveda

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE817B01025
  • NSEID:
  • BSEID: 530163
INR
212.50
6.55 (3.18%)
BSENSE

May 06

BSE+NSE Vol: 8.8 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 288880,
    "name": "Kerala Ayurveda",
    "stock_name": "Kerala Ayurveda",
    "full_name": "Kerala Ayurveda Ltd",
    "name_url": "stocks-analysis/kerala-ayurveda",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 0,
    "country_id": 34,
    "currency": "INR",
    "cmp": "212.50",
    "chg": 6.55,
    "chgp": "3.18%",
    "dir": 1,
    "prev_price": "205.95",
    "mcapval": "269.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 530163,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE817B01025",
    "curr_date": "May 06",
    "curr_time": "",
    "bse_nse_vol": "8.8 k",
    "exc_status": "Active",
    "traded_date": "May 06, 2026",
    "traded_date_str": "2026 05 06",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/kerala-ayurveda-288880-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Kerala Ayurveda Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/kerala-ayurveda-ltd-is-rated-strong-sell-3963123",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/KeralaAyurvedaL_mojoScore_3963123.png",
        "date": "2026-04-26 10:10:13",
        "description": "Kerala Ayurveda Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 11 August 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 26 April 2026, providing investors with an up-to-date view of the stock’s fundamentals, valuation, financial trend, and technical outlook."
      },
      {
        "title": "Kerala Ayurveda Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/kerala-ayurveda-ltd-is-rated-strong-sell-3947347",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/KeralaAyurvedaL_mojoScore_3947347.png",
        "date": "2026-04-15 10:10:17",
        "description": "Kerala Ayurveda Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 11 August 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 15 April 2026, providing investors with the latest insights into the company’s performance and outlook."
      },
      {
        "title": "Kerala Ayurveda Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/kerala-ayurveda-ltd-is-rated-strong-sell-3933005",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/KeralaAyurvedaL_mojoScore_3933005.png",
        "date": "2026-04-04 10:10:13",
        "description": "Kerala Ayurveda Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 11 August 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 04 April 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Markets Rally, But Kerala Ayurveda Ltd Sinks to 52-Week Low in Stock-Specific Sell-Off",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/kerala-ayurveda-ltd-stock-hits-52-week-low-amidst-continued-downtrend-3925070",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/KeralaAyurvedaL_priceRelatedfactors_3925070.png",
        "date": "2026-03-30 13:32:38",
        "description": "Despite a broader market recovery, Kerala Ayurveda Ltd has plunged to a fresh 52-week low of Rs 150 on 30 Mar 2026, extending its recent losing streak and underperforming its sector by 2.79% today."
      },
      {
        "title": "Kerala Ayurveda Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/kerala-ayurveda-ltd-is-rated-strong-sell-3909780",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/KeralaAyurvedaL_mojoScore_3909780.png",
        "date": "2026-03-24 10:10:16",
        "description": "Kerala Ayurveda Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 11 August 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 24 March 2026, providing investors with an up-to-date view of the stock’s fundamentals, valuation, financial trend, and technical outlook."
      },
      {
        "title": "Kerala Ayurveda Ltd Stock Falls to 52-Week Low of Rs.161.05",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/kerala-ayurveda-ltd-stock-falls-to-52-week-low-of-rs16105-3896517",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/KeralaAyurvedaL_priceRelatedfactors_3896517.png",
        "date": "2026-03-17 11:00:20",
        "description": "Kerala Ayurveda Ltd’s shares touched a fresh 52-week low of Rs.161.05 today, marking a significant decline amid ongoing pressures in the Pharmaceuticals & Biotechnology sector. Despite a volatile trading session, the stock remains below all key moving averages, reflecting persistent downward momentum."
      },
      {
        "title": "Kerala Ayurveda Ltd Stock Falls to 52-Week Low of Rs.162",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/kerala-ayurveda-ltd-stock-falls-to-52-week-low-of-rs162-3894340",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/KeralaAyurvedaL_priceRelatedfactors_3894340.png",
        "date": "2026-03-16 15:45:01",
        "description": "Kerala Ayurveda Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has touched a new 52-week low of Rs.162 today, marking a significant decline amid sustained downward momentum. The stock has underperformed its sector and broader market indices, reflecting ongoing pressures on its financial and market performance."
      },
      {
        "title": "Kerala Ayurveda Ltd Stock Falls to 52-Week Low of Rs.163.7",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/kerala-ayurveda-ltd-stock-falls-to-52-week-low-of-rs1637-3890092",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/KeralaAyurvedaL_priceRelatedfactors_3890092.png",
        "date": "2026-03-13 19:22:14",
        "description": "Kerala Ayurveda Ltd’s shares fell sharply to a new 52-week low of Rs.163.7 on 13 Mar 2026, marking a significant decline amid ongoing pressures in the Pharmaceuticals & Biotechnology sector. The stock has underperformed its peers and broader market indices, reflecting persistent financial and market challenges."
      },
      {
        "title": "Kerala Ayurveda Ltd Stock Falls to 52-Week Low of Rs.180",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/kerala-ayurveda-ltd-stock-falls-to-52-week-low-of-rs180-3886852",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/KeralaAyurvedaL_priceRelatedfactors_3886852.png",
        "date": "2026-03-12 10:22:09",
        "description": "Kerala Ayurveda Ltd, a player in the Pharmaceuticals & Biotechnology sector, has touched a new 52-week low of Rs.180 today, marking a significant decline amid ongoing market pressures and company-specific headwinds. The stock has underperformed its sector and broader market indices, reflecting persistent challenges in its financial and technical performance."
      }
    ],
    "total": 242,
    "sid": "288880",
    "stock_news_url": "https://www.marketsmojo.com/news/kerala-ayurveda-288880"
  },
  "announcements": [
    {
      "caption": "Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A",
      "datetime": "27-Apr-2026",
      "details": "<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=1px><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> </tr> <tr><td>1</td><td>Name of Company</td><td>Kerala Ayurveda Ltd</td></tr> <tr><td>2</td><td>CIN NO.</td><td>L24233KL1992PLC006592</td></tr> <tr><td>3</td> <td>Outstanding borrowing of company as on 31st March / 31st December as applicable (in Rs cr)</td> <td>70.47</td></tr> <tr><td>4</td><td>Highest Credit Rating during the previous FY </td><td>NIL</td></tr> <tr><td>4a</td><td>Name of the Credit Rating Agency issuing the Credit Rating mentioned in (4)</td><td>Not Applicable</td></tr> <tr><td>5</td><td>Name of Stock Exchange# in which the fine shall be paid in case of shortfall in the required borrowing under the framework</td><td>BSE</td></tr> </table> <br/><br/> <div> <div style=float:left;> We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26 2018. No</div> <br/><br/><br/> <div style=float:left;> Name of the Company Secretary: The Company is in the process of appointing a Company Secretary <br/> Designation: Kunjupanicker Anil Kumar Wholetime Director <br/> EmailId: info@keralaayurveda.biz</div> <div style=float:left;margin-left:50px;> Name of the Chief Financial Officer: George K T <br/> Designation: Chief Financial Officer <br/> EmailId: ktgeorge@keralaayurveda.com</div> </div> <div> <br/> Date: 27/04/2026<br/><br/> <b>Note:<b> In terms para of 3.2(ii) of the circular beginning F.Y 2022 in the event of shortfall in the mandatory borrowing through debt securities a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore an entity identified as LC shall provide in its initial disclosure for a financial year the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets. </div>",
      "source": "BSE"
    },
    {
      "caption": "Announcement Under Regulation 30 (LODR)",
      "datetime": "16-Apr-2026",
      "details": "Announcement Under Regulation 30 (LODR)",
      "source": "BSE"
    },
    {
      "caption": "Clarification sought from Kerala Ayurveda Ltd",
      "datetime": "08-Apr-2026",
      "details": "The Exchange has sought clarification from Kerala Ayurveda Ltd on April 8 2026 with reference to significant movement in price in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded.<BR><BR>The reply is awaited.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views
stock-recommendationAnnouncement

Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A

27-Apr-2026 | Source : BSE

Format of Initial Disclosure to be made by an entity identified as a Large Corporate.

Sr. No. Particulars Details
1Name of CompanyKerala Ayurveda Ltd
2CIN NO.L24233KL1992PLC006592
3 Outstanding borrowing of company as on 31st March / 31st December as applicable (in Rs cr) 70.47
4Highest Credit Rating during the previous FY NIL
4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)Not Applicable
5Name of Stock Exchange# in which the fine shall be paid in case of shortfall in the required borrowing under the frameworkBSE


We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26 2018. No



Name of the Company Secretary: The Company is in the process of appointing a Company Secretary
Designation: Kunjupanicker Anil Kumar Wholetime Director
EmailId: info@keralaayurveda.biz
Name of the Chief Financial Officer: George K T
Designation: Chief Financial Officer
EmailId: ktgeorge@keralaayurveda.com

Date: 27/04/2026

Note: In terms para of 3.2(ii) of the circular beginning F.Y 2022 in the event of shortfall in the mandatory borrowing through debt securities a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore an entity identified as LC shall provide in its initial disclosure for a financial year the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.

Announcement Under Regulation 30 (LODR)

16-Apr-2026 | Source : BSE

Announcement Under Regulation 30 (LODR)

Clarification sought from Kerala Ayurveda Ltd

08-Apr-2026 | Source : BSE

The Exchange has sought clarification from Kerala Ayurveda Ltd on April 8 2026 with reference to significant movement in price in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded.

The reply is awaited.

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available